EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Current Insight into Human Ornithine Aminotransferase: A Review

Fulvio Floriani, Carla Borri Voltattorni, Riccardo Montioli

Proteins: Structure, Function, and Bioinformatics · 2026

DOI: 10.1002/prot.70134 ↗

At a glance

Übersichtsarbeit in Proteins: Structure, Function, and Bioinformatics, 2026. Written by Fulvio Floriani and 2 co-authors. Institution: Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Verona, Italy. Major MEDLINE topics: Ornithine-Oxo-Acid Transaminase, Gyrate Atrophy. Cited 2 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Human ornithine aminotransferase (hOAT) is a mitochondrial matrix pyridoxal‐5′‐phosphate enzyme (PLP) that catalyzes the reversible transfer of the δ‐amino group of L‐ornithine (L‐Orn) to α‐ketoglutarate (α‐KG) yielding glutamate‐5‐semialdehyde (GSA) and glutamate. GSA is prone to cyclize to Δ1‐pyrroline‐5‐carboxylate. Human OAT holds significant clinical and scientific interest because (i) its dysfunction causes gyrate atrophy (GA) of the choroid and retina, a rare autosomal recessive disease, and (ii) it is recognized as a potential target for chemotherapeutic drug development, being overexpressed in some types of cancer. Here, we review the kinetic and structural features of the enzyme, as well as the mechanistic aspects of hOAT inhibition. Moreover, we focus our attention on the characterization of the structural and functional properties of the artificial variants and of those associated with GA. Considering that great progress toward the characterization of the pathogenic variants has been reached in the last few years, we summarize here, by revisiting the data available on the hOAT and its variants as purified recombinant form, the current understanding of (i) the molecular defect(s) of studied disease‐causing mutations and (ii) the residues (particularly, active site residues critical for dictating the reaction specificity) and/or regions of the enzyme crucial for its folding and/or catalytic properties.

Subjects

MeSH terms (MEDLINE)

Ornithine-Oxo-Acid TransaminaseGyrate AtrophyHumansModels, MolecularKineticsMutationCatalytic DomainRecombinant ProteinsSubstrate SpecificityOrnithine

Author keywords

molecular effects of mutationsornithine aminotransferasepathogenic variantspyridoxal‐5′‐phosphate

Substances

Ornithine-Oxo-Acid TransaminaseOAT protein, humanRecombinant ProteinsOrnithine

Authors and institutions

  • Department of Neuroscience, Biomedicine, and Movement Sciences, Biological Chemistry Section, University of Verona, Verona, Italy.

Cite

APA

Floriani, F., Borri Voltattorni, C., & Montioli, R. (2026). Current Insight into Human Ornithine Aminotransferase: A Review. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.70134

Vancouver

Floriani F, Borri Voltattorni C, Montioli R. Current Insight into Human Ornithine Aminotransferase: A Review. Proteins: Structure, Function, and Bioinformatics. 2026. doi:10.1002/prot.70134

BibTeX
@article{Floriani2026,
  author = {Floriani, Fulvio and Borri Voltattorni, Carla and Montioli, Riccardo},
  title = {Current Insight into Human Ornithine Aminotransferase: A Review},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2026},
  doi = {10.1002/prot.70134}
}
Start for free →